Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC

Abstract Background Stereotactic ablative radiotherapy (SABR) is thought to activate T cell responses in patients with cancer, leading to its combination with immunotherapy and chemotherapy for treatment of non-small-cell lung cancer (NSCLC). Here, we aimed to provide a high-resolution transcriptomi...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Chao Liu, Yanjuan Chen, Xiaohui Li, Zhijie Bai, Meilin Jiang, Dongsheng Sheng, Wenxue Zou, Rui Huang, Qingyu Huang, Fuhao Wang, Jingyang Zhu, Huiru Sun, Bing Liu, Zongcheng Li, Bing Sun
Format:	Artigo
Jezik:	Inglês
Izdano:	Springer 2025-02-01
Serija:	Cancer Immunology, Immunotherapy
Teme:	SABR Non-small-cell lung cancer Immunotherapy Single-cell RNA sequencing Immune response
Online dostop:	https://doi.org/10.1007/s00262-024-03935-8
Oznake:	Označite Brez oznak, prvi označite!